Monthly Archives: March 2010
Coffee Lower the Risk of Arrhythmia?
Coffee drinkers who have been drinking coffee for a long time have another reason to continue their drinking habit. A new study presented in the Cardiovascular Disease Epidemiology and Prevention and Nutrition, Physical Activity, and Metabolism 2010 Conference indicated that … Continue reading
Atrial Fibrillation – Causes, Symptoms, Diagnosis, Prognosis and Latest Treatment
If you have heart beat that is quicker than 60-80 beats per minute at rest or 90-115 beats per minutes during exercise, you might have fast and irregular heart beat or arrhythmia. There are different kinds of arrhythmia but atrial … Continue reading
Best Regimen Sequence for Early Breast Cancer patients
Which is the best chemotherapy adjuvant regimen sequence for early breast cancer? It is widely known that anthracyclines (epirubicin and doxorubicin) and taxanes is the best adjuvant chemotherapy regimen for early breast cancer. However, should anthracyclines be always administered before taxanes? An article published … Continue reading
Lose Weight, regardless of Diet Intervention, can Shrink the Plague in Carotid Artery
A study published in the March issue of the Circulation indicated that people who lost weight by one of the three diets 1) low fat, 2) Mediterranean or 3) low carbohydrate can have the plagues in their carotid artery (the … Continue reading
Cancer Protective Benefits of Bisphosphonates
Patients who are taking bisphosphonates products (Fosamax, Actonel and Boniva) might have a lower risk of getting breast cancer. A study published in the February issue of the British Journal of Cancer looked at the consumption of bisphosphonate products in … Continue reading
Alternative Treatment Options for Late Stage Lung Cancer Patients
Paclitaxel plus carboplatin(PC) is the current standard regimen for advanced or metastatic non-small-cell lung cancer (NSCLC) patients. However, paclitaxel is associated with serious toxicity such as peripheral neuropathy. A tria,l published in October version of the Annals of Oncology, was … Continue reading
New Drug Offer Hope to Patients with Late Stage Prostate Cancer
At present, metastatic and hormonal-refractory prostate cancer patients who have failed 1st line chemotherapy will be given mitoxantrone plus prednisone as the salvage therapy. However, mitoxantrone plus prednisone is not very effective in controlling metastatic prostate cancer. Now, a new … Continue reading